
RABINTA-L 40
MRP: 2,100
Packaging: 10x10
Pack Type: tablet
Composition:
Rabeprazole Sodium 40mg + Levosulpiride (sustained release form) 75mg
Indication:
DIABETIC GASTROPARESIS, DYSPEPSIA, GERD, IBS & Intestinal Ulcers
Description:
This combination of Rabeprazole Sodium 40 mg (Enteric-Coated) and Levosulpiride 75 mg (Sustained Release) is formulated for the management of GERD (Gastroesophageal Reflux Disease), functional dyspepsia, bloating, and chronic gastritis.
Rabeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme in parietal cells, thus promoting ulcer healing and reducing heartburn.
Levosulpiride is a substituted benzamide derivative with prokinetic and antipsychotic properties, which enhances gastrointestinal motility and provides symptomatic relief from bloating, nausea, and delayed gastric emptying. It acts as a selective dopamine D2 antagonist, promoting gastric emptying and reducing visceral sensitivity.
This synergistic combination offers both acid suppression and prokinetic action, making it highly effective in treating acid-related disorders with motility dysfunction.
Tags:
- Provides dual action: acid suppression + improved GI motility
- Reduces heartburn, bloating, nausea, and fullness
- Treats GERD, functional dyspepsia, and gastritis
- Once-daily dosing for better compliance
- Promotes faster gastric emptying
- Helps in chronic indigestion with reflux symptoms
Usage Information
Dosage
Adults: Take one capsule daily, preferably 30 minutes before breakfast or as advised by your doctor. Do not chew or crush the capsule. Swallow whole with water.
Side Effects
Common: Headache, dizziness, nausea, diarrhea, abdominal discomfort Levosulpiride-related: Fatigue, restlessness, breast tenderness (rare), menstrual irregularities Long-term use: May cause extrapyramidal symptoms, hyperprolactinemia, or galactorrhea in some patients
Contraindications
Hypersensitivity to Rabeprazole, Levosulpiride, or related compounds Epilepsy or seizure disorders Parkinson’s disease Patients with gastrointestinal hemorrhage, obstruction, or perforation Pregnant or lactating women (use only under medical advice) History of prolactin-dependent tumors
Availability
Rabeprazole Levosulpiride capsule Acid reflux and bloating treatment GERD prokinetic medicine Rabeprazole 40mg with Levosulpiride 75mg Functional dyspepsia medication Hyperacidity and motility disorder treatment Prokinetic PPI combination Gastritis treatment capsule Sustained release Levosulpiride Delayed gastric emptying medicine
